Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
Brian Schulte, Nisha Mohindra, Mohammed Milhem, Steven Attia, Steven I. Robinson, Varun Monga, Angela C. Hirbe, Peter Oppelt, John A. Charlson, Irene Helenowski, Susan Abbinanti, Rasima Cehic, Scott H. Okuno, Brian Andrew Van Tine, Mark Agulnik
Topics & Concepts
PazopanibTopotecanMedicineSoft tissueSarcomaBone SarcomaOncologyPhases of clinical researchInternal medicineChemotherapySurgeryCancerPathologySunitinibSarcoma Diagnosis and TreatmentAngiogenesis and VEGF in CancerCancer Research and Treatments